4.7 Article

The histone demethylase Jarid1b is required for hematopoietic stem cell self-renewal in mice

Journal

BLOOD
Volume 125, Issue 13, Pages 2075-2078

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2014-08-596734

Keywords

-

Categories

Funding

  1. Kay Kendall Leukaemia Fund
  2. Merton College Oxford
  3. EMBO
  4. Danish Medical Research Council
  5. Leukaemia and Lymphoma Research
  6. Cancer Research UK
  7. Cancer Research UK [12796] Funding Source: researchfish
  8. Great Ormond Street Hospital Childrens Charity [W1062] Funding Source: researchfish
  9. Medical Research Council [MC_U137973817, MR/M009033/1] Funding Source: researchfish
  10. MRC [MR/M009033/1, MC_U137973817] Funding Source: UKRI

Ask authors/readers for more resources

Jarid1b/KDM5bis a histone demethylase that regulates self-renewal and differentiation in stem cells and cancer; however, its function in hematopoiesis is unclear. Here, we find that Jarid1b is highly expressed in primitive hematopoietic compartments and is over-expressed in acute myeloid leukemias. Constitutive genetic deletion of Jarid1b did not impact steady-state hematopoiesis. In contrast, acute deletion of Jarid1b from bone marrow increased peripheral blood T cells and, following secondary transplantation, resulted in loss of bone marrow reconstitution. Our results reveal that deletion of Jarid1b compromises hematopoietic stem cell (HSC) self-renewal capacity and suggest that Jarid1b is a positive regulator of HSC potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available